Veeva Systems Inc. (VEEV) reported a robust performance in the first quarter of fiscal 2026, exceeding earnings and revenue expectations. The company, which specializes in cloud-based software for the life sciences industry, has a market capitalization of $46.1 billion and anticipates a 26.2% growth over the next five years. Year-to-date, VEEV shares have risen by 31.7%, outpacing the industry growth of 19.9% amid the S&P 500’s decline of 8.5%.
For the second quarter of fiscal 2026, analysts project revenues of $767.6 million, reflecting a 13.5% increase from the prior year, with an earnings per share (EPS) estimate of $1.90, indicating a 17.3% year-over-year improvement. Recent strategic deals, including partnerships with Boehringer Ingelheim and Walgreens Boots Alliance, along with innovations like Veeva AI, are expected to further bolster growth. However, rising operational costs remain a concern, with a 9.4% increase in total operating expenses reported for Q1.
